Carregant...
Bevacizumab maintenance in metastatic colorectal cancer: How long?
The management of patients with non-progressive metastatic colorectal cancer after six months of treatment has not yet been codified. The most relevant concerns are the effectiveness of maintenance vs discontinuation, and the tolerability of prolonged treatment. Here we report the case of a 72-year-...
Guardat en:
Publicat a: | World J Clin Cases |
---|---|
Autors principals: | , , , , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Baishideng Publishing Group Inc
2014
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4233413/ https://ncbi.nlm.nih.gov/pubmed/25405197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v2.i11.717 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|